| 2024 | | Financial Benefits of Renal Dose-Adjusted Dipeptidyl Peptidase-4 Inhibitors for Patients with Type 2 Diabetes and Chronic Kidney Disease | 김대중, 하경화 |
| 2024 | | Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study | 김대중, 하경화 |
| 2024 | | Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations | 김대중, 하경화 |
| 2023 | | Impact of prolonged carbapenem use-focused antimicrobial stewardship on antimicrobial consumption and factors affecting acceptance of recommendations: a quasi-experimental study | 김영롱, 김은진, 유진세, 최영화, 하경화, 허중연 |
| 2023 | | Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia | 김대중, 하경화 |
| 2023 | | Long-term Effectiveness of the National Diabetes Quality Assessment Program in South Korea | 김대중, 하경화 |
| 2023 | | Diet quality partially mediates the association between ultraprocessed food consumption and adiposity indicators | 김대중, 하경화 |
| 2023 | | Associations of updated cardiovascular health metrics, including sleep health, with incident diabetes and cardiovascular events in older adults with prediabetes: A nationwide population-based cohort study | 김대중, 하경화, 한승진 |
| 2023 | | Ultra-Processed Food Consumption and Obesity in Korean Adults | 김대중, 하경화 |
| 2023 | | Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study | 김대중, 하경화 |
| 2023 | | Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes | 김대중, 하경화 |
| 2023 | | Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study | 김대중, 하경화 |
| 2022 | | Association of prediabetes with death and diabetic complications in older adults: The pros and cons of active screening for prediabetes | 김대중, 하경화 |
| 2022 | | Maintaining Physical Activity Is Associated with Reduced Major Adverse Cardiovascular Events in People Newly Diagnosed with Diabetes | 김대중, 하경화 |
| 2022 | | Rising Incidence of Diabetes in Young Adults in South Korea: A National Cohort Study | 김대중, 하경화 |
| 2022 | | Association between Metabolically Healthy Obesity and Subclinical Atherosclerosis in the Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) Cohort | 김대중, 하경화 |
| 2022 | | Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study | 김대중, 하경화 |
| 2022 | | Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data | 김대중, 하경화 |
| 2022 | | Temporal Association of Total Serum Cholesterol and Pancreatic Cancer Incidence | 하경화 |
| 2022 | | Short-Term Air Pollution Exposure and Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea: A National Time-Stratified Case-Crossover Study | 김대중, 김은진, 정윤정, 최영화, 하경화, 허중연 |
| 2022 | | Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real-world clinical practice in Korea: A national observational cohort study | 김대중, 최용준, 하경화 |
| 2022 | | Healthcare resource utilization in patients treated with empagliflozin in East Asia | 김대중, 하경화 |
| 2021 | | Erratum: Trends in cardiovascular complications and mortality among patients with diabetes in South Korea | 김대중, 하경화 |
| 2021 | | Air pollution and risk of hospital outpatient visits for eczematous skin disorders in metropolitan cities of South Korea | 하경화 |
| 2021 | | Effect of teneligliptin versus sulfonylurea on major adverse cardiovascular outcomes in people with type 2 diabetes mellitus: A real-world study in Korea | 김대중, 하경화 |
| 2021 | | Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings | 김대중, 하경화 |
| 2021 | | Trends in cardiovascular complications and mortality among patients with diabetes in South Korea | 김대중, 하경화 |
| 2021 | | Cardiovascular safety of sodium glucose cotransporter 2 inhibitors as add-on to metformin monotherapy in patients with type 2 diabetes mellitus | 김대중, 전자영, 하경화 |
| 2021 | | Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A nationwide population-based study | 김대중, 이나미, 하경화, 한승진 |
| 2021 | | Trends in the effects of pre-transplant diabetes on mortality and cardiovascular events after kidney transplantation | 박범희, 오창권, 전자영, 하경화, 한승진 |
| 2021 | | Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study | 김대중, 하경화 |
| 2020 | | Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study | 김대중, 하경화 |
| 2020 | | Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database | 하경화 |
| 2020 | | Trends in the Incidence, Prevalence, and Mortality of End-Stage Kidney Disease in South Korea | 김대중, 박인휘, 이민정, 하경화 |
| 2020 | | Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study | 김대중, 하경화 |
| 2020 | | Diabetic Retinopathy and Related Clinical Practice for People with Diabetes in Korea: A 10-Year Trend Analysis | 김대중, 이기황, 정유리, 하경화 |
| 2019 | | Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640-8) | 김대중, 이기황, 정유리, 하경화 |
| 2019 | | Diabetes and the Risk of Infection: A National Cohort Study | 김대중, 김은진, 최영화, 하경화 |
| 2019 | | Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status | 김대중, 하경화 |
| 2019 | | Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study | 김대중, 이기황, 정유리, 하경화 |
| 2019 | | Cohort Profile: The Cardiovascular and Metabolic Diseases Etiology Research Center Cohort in Korea | 김대중, 하경화 |
| 2019 | | Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study | 김대중, 하경화 |
| 2019 | | The Association of Adiponectin and Visceral Fat with Insulin Resistance and beta-Cell Dysfunction | 김대중, 김혜진, 문현욱, 하경화, 한승진 |
| 2019 | | Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study | 김대중, 이기황, 정유리, 하경화 |
| 2018 | | Blood adiponectin levels are not associated with risk of cardiovascular events in patients with type 2 diabetes | 김대중, 김혜진, 이관우, 전자영, 하경화, 한승진 |
| 2018 | | Combined effects of diabetes and low household income on mortality: a 12-year follow-up study of 505 677 Korean adults | 김대중, 하경화 |
| 2018 | | Can persistent organic pollutants distinguish between two opposite metabolic phenotypes in lean Koreans? | 김대중, 하경화 |
| 2018 | | Long-term patterns of fasting blood glucose levels and pancreatic cancer incidence | 하경화 |
| 2018 | | Association of Body Mass Index with Risk of Major Adverse Cardiovascular Events and Mortality in People with Diabetes | 김대중, 하경화 |
| 2018 | | Development and Validation of the Korean Diabetes Risk Score: A 10-Year National Cohort Study | 김대중, 하경화 |
